DEMANT:OMXCOPDemant A/S Analysis
Data as of 2026-06-12 - not real-time
DKK 251.20
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Demant A/S is trading well above its 20‑day and 50‑day moving averages, reflecting a bullish price trend, yet the MACD histogram has turned negative, signaling emerging bearish momentum. The RSI sits in the high‑40s% range, indicating the stock is approaching overbought conditions. Recent earnings commentary highlights 6% organic revenue growth, driven by double‑digit gains in hearing aids and a successful new product launch, reinforcing the company's strong operating margins. However, the discounted cash flow model suggests a fair value far below the current market price, and the balance sheet shows a very high debt‑to‑equity ratio, raising concerns about financial leverage. With increasing volume and an “Extreme Greed” sentiment index, short‑term upside may be limited while the long‑term outlook hinges on sustained growth and debt reduction.
Overall, the stock presents a mixed picture: robust fundamentals and market leadership are tempered by valuation pressure, elevated leverage, and technical signs of potential pullback.
Overall, the stock presents a mixed picture: robust fundamentals and market leadership are tempered by valuation pressure, elevated leverage, and technical signs of potential pullback.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price is near resistance with bullish trend but MACD shows early bearish divergence
- RSI approaching overbought territory
- Recent earnings beat supports near‑term confidence
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Consistent organic revenue growth and strong hearing‑aid segment
- Expansion of executive leadership team signals strategic focus
- Valuation remains above fair value, creating a cushion for potential correction
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High debt‑to‑equity ratio limits financial flexibility
- No dividend payout reduces income appeal
- Sustainable competitive advantage in hearing‑care offsets valuation concerns
Key Metrics & Analysis
Financial Health
Revenue Growth3.40%
Profit Margin6.73%
P/E Ratio22.4
ROE24.20%
ROA6.93%
Debt/Equity211.59
P/B Ratio5.4
Op. Cash FlowDKK4.0B
Free Cash FlowDKK3.3B
Industry P/E24.8
Technical Analysis
TrendBullish
RSI62.8
SupportDKK 226.20
ResistanceDKK 265.00
MA 20DKK 245.22
MA 50DKK 222.48
MA 200DKK 218.89
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair ValueDKK 145.13
Target PriceDKK 247.68
Upside/Downside-1.40%
GradeOvervalued
TypeBlend
Risk Assessment
Beta0.52
Volatility46.88%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.